Leukosite (LKST)promising new biotech Cy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Leukosite (LKST)promising new biotech Cy?

LKST 4.260

0.0%

May 29 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. Id who wrote (23)	3/28/1999 10:46:00 PM
From: ACC	Read Replies (1) of 35

< Any idea why this stock has been sinking? > None at all - seems to be drifting back to baseline on lack of any investment-worthy news... like so many of the small biotechs, movement seems to be based on whether or not WSJ or NYT decides to write them up. It's interesting that LKST is licensed to develop Campath-1H for oncology application and not other possibilities, but now has acquired anti-CD3 for development in transplantation from BTG: biz.yahoo.com My memory fails me - what is the target for Campath-1H? ACC

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next